subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D

object_name: nutritional supplement toxicity

tested_intervention: unsure


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: MESH:D002136

subject_name: Calcium, Dietary


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: CHEBI:176842

subject_name: vitamin B9


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0678449

object_name: Dyspnea


subject: UMLS:C0678449

object_name: Exercise intolerance


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C0308222

subject_name: ACTH Gel

object_name: uveitis

tested_intervention: yes


subject: UMLS:C0308222

object_name: Uveitis, CTCAE


subject: CHEBI:60799

subject_name: Esketamine

object_name: Fusion of spine (disease)


subject: CHEBI:9168

subject_name: Sirolimus

object_name: atypical teratoid rhabdoid tumor


subject: CHEBI:9168

object_name: Childhood Atypical Teratoid/Rhabdoid Tumor


subject: CHEBI:9168

object_name: clear cell sarcoma


subject: CHEBI:9168

object_name: medulloblastoma


subject: CHEBI:9168

object_name: childhood medulloblastoma


subject: CHEBI:9168

object_name: adult medulloblastoma


subject: CHEBI:9168

object_name: hepatoblastoma


subject: CHEBI:9168

object_name: retinoblastoma


subject: CHEBI:9168

object_name: Childhood Astrocytoma


subject: CHEBI:9168

object_name: glioma susceptibility 1


subject: CHEBI:9168

object_name: astrocytic tumor


subject: CHEBI:9168

object_name: astrocytoma


subject: CHEBI:9168

object_name: ependymoma


subject: CHEBI:9168

object_name: childhood ependymoma


subject: CHEBI:9168

object_name: Newly Diagnosed Childhood Ependymoma


subject: CHEBI:9168

object_name: Adult Ependymoma


subject: CHEBI:9168

object_name: glioma


subject: CHEBI:9168

object_name: malignant glioma


subject: CHEBI:32682

subject_name: L-argininium

object_name: Sepsis


subject: CHEBI:32682

object_name: Sepsis, CTCAE


subject: CHEBI:32682

object_name: septic shock


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:29952


subject: CHEBI:29952


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:16467


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: influenza


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:7507

subject_name: Framycetin


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: cervical cancer


subject: CHEBI:35475

object_name: cervical carcinoma


subject: CHEBI:35475

object_name: endometrial carcinoma


subject: CHEBI:35475

object_name: ovarian cancer


subject: CHEBI:35475

object_name: ovarian neoplasm


subject: CHEBI:35475

object_name: ovarian carcinoma


subject: UMLS:C0242896

subject_name: Anticholinergic Agents

object_name: urinary system disorder


subject: UMLS:C3537004

subject_name: Anticholinergic [EPC]


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: rectal carcinoma


subject: CHEBI:41879

object_name: rectal cancer


subject: CHEBI:41879

object_name: Childhood Rectal Carcinoma


subject: UNII:C9H2L21V7U

subject_name: SMOFlipid

object_name: total parenteral nutrition


subject: UNII:C9H2L21V7U

object_name: chronic liver failure


subject: CHEBI:31607

subject_name: Ferrous fumarate

object_name: Iron absorption level


subject: CHEBI:31608

subject_name: ferrous gluconate


subject: PUBCHEM.COMPOUND:146212008

object_name: Recurrent Malignant Neoplasm


subject: PUBCHEM.COMPOUND:146212008

object_name: Recurrent Carcinoma


subject: PUBCHEM.COMPOUND:146212008

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:146212008

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:146212008

object_name: Metastasis


subject: PUBCHEM.COMPOUND:146212008

object_name: Metastatic Lesion


subject: PUBCHEM.COMPOUND:146212008

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UMLS:C5557419

subject_name: ATM Kinase/DNA-PK Inhibitor XRD-0394


subject: UMLS:C5557419


subject: UMLS:C5557419


subject: UMLS:C5557419


subject: UMLS:C5557419


subject: UMLS:C5557419


subject: UMLS:C5557419


subject: CHEBI:184472

subject_name: Nitrofurantoin

object_name: Complication of surgical procedure


subject: CHEBI:3515

subject_name: Cefuroxime


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN


subject: CHEBI:63598

subject_name: Levofloxacin


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:33330

subject_name: scandium atom


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: CHEBI:7307

subject_name: Methyl pyrrolidone

object_name: plasma cell myeloma


subject: UMLS:C0722498

subject_name: Patanol

object_name: atopic conjunctivitis


subject: PR:000004274

subject_name: ADP-ribosylation factor-like protein 10

object_name: coronary artery disorder


subject: PR:000004274

object_name: Dyslipidemia


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: PUBCHEM.COMPOUND:521372


subject: CHEBI:90217

subject_name: Quizartinib

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:90217

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UMLS:C3537002

subject_name: Anti-epileptic Agent [EPC]

object_name: epilepsy


subject: UMLS:C3537002

object_name: drug rash with eosinophilia and systemic symptoms


subject: UMLS:C4510275

subject_name: Sulfur hexafluoride lipid microsphere

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4510275

object_name: clear cell renal carcinoma


subject: UMLS:C4510275

object_name: renal cell adenocarcinoma


subject: UMLS:C4510275

object_name: renal cell carcinoma


subject: UMLS:C4510275

object_name: Renal cell carcinoma recurrent


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:41879

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:9434

subject_name: Telmisartan

object_name: Parkinson disease


subject: CHEBI:9445

subject_name: Terazosin


subject: PUBCHEM.COMPOUND:9803362

subject_name: Hytrin


subject: UMLS:C0591628


subject: CHEBI:7852

subject_name: Oxycodone

object_name: anxiety disorder


subject: CHEBI:7852

object_name: Depressed mood


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Plasmodium falciparum malaria


subject: UNII:C82R061MZ5

object_name: inherited lipid metabolism disorder


subject: UNII:C82R061MZ5

object_name: Dyslipidemia


subject: UNII:8JYO8VTR11


subject: UNII:8JYO8VTR11


subject: UMLS:C1174747

subject_name: Iscover

object_name: myocardial infarction


subject: UMLS:C1174747

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C1174747

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:27470

subject_name: Folic acid

object_name: megaloblastic anemia


subject: CHEBI:27470

object_name: Depressive Symptoms


subject: UMLS:C0021735

subject_name: Viraferon

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: UMLS:C0021735

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: UMLS:C0021735

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: GTOPDB:9311

subject_name: urelumab

object_name: urothelial carcinoma


subject: GTOPDB:9311

object_name: transitional cell carcinoma


subject: GTOPDB:9311

object_name: bladder tumor


subject: GTOPDB:9311

object_name: urinary bladder carcinoma


subject: GTOPDB:9311

object_name: urinary bladder cancer


subject: GTOPDB:9311

object_name: childhood bladder carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743085

subject_name: URELUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743085


subject: CHEMBL.COMPOUND:CHEMBL1743085


subject: CHEMBL.COMPOUND:CHEMBL1743085


subject: CHEMBL.COMPOUND:CHEMBL1743085


subject: CHEMBL.COMPOUND:CHEMBL1743085


subject: UMLS:C1831875


subject: UMLS:C1831875


subject: UMLS:C1831875


subject: UMLS:C1831875


subject: UMLS:C1831875


subject: UMLS:C1831875


subject: UMLS:C5557646

object_name: prostate adenocarcinoma


subject: CHEBI:50634

object_name: pulmonary edema of mountaineers, susceptibility to


subject: CHEBI:50634

object_name: high altitude pulmonary edema


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:94805

subject_name: Ataluren

object_name: qualitative or quantitative defects of dystrophin


subject: UMLS:C2984015

object_name: liver carcinoma


subject: UNII:Q830PW7520

subject_name: CODEINE

object_name: Edema


subject: UNII:Q830PW7520

object_name: Trismus


subject: UNII:Q830PW7520

object_name: Trismus, CTCAE


subject: PUBCHEM.COMPOUND:2828


subject: PUBCHEM.COMPOUND:2828


subject: PUBCHEM.COMPOUND:2828


subject: CHEBI:57871


subject: CHEBI:57871


subject: CHEBI:57871


subject: CHEBI:16714

subject_name: Codeine


subject: CHEBI:16714


subject: CHEBI:16714


subject: UMLS:C5669600

subject_name: Ivonescimab

object_name: Advanced Lung Non-Small Cell Squamous Carcinoma


subject: CHEBI:135173

subject_name: Taurolidine

object_name: Infection


subject: CHEBI:135173

object_name: infectious disease


subject: CHEBI:135173

object_name: Adverse Event Associated with Infection


subject: CHEBI:135173

object_name: total parenteral nutrition


subject: CHEBI:135173

object_name: Sepsis


subject: CHEBI:135173

object_name: Sepsis, CTCAE


subject: CHEBI:8382

subject_name: Prednisone

object_name: chronic ethmoidal sinusitis


subject: CHEBI:8382

object_name: chronic sphenoidal sinusitis


subject: CHEBI:8382

object_name: Chronic frontoethmoidal sinusitis


subject: CHEBI:8382

object_name: Chronic bilateral maxillary sinusitis


subject: CHEBI:229764

subject_name: Selinexor

object_name: mixed phenotype acute leukemia


subject: CHEBI:229764

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:229764

object_name: acute lymphoblastic leukemia


subject: CHEBI:229764

object_name: adult acute lymphoblastic leukemia


subject: CHEBI:93775

subject_name: Amethopterin

object_name: adult acute myeloid leukemia


subject: CHEBI:93775

object_name: childhood acute myeloid leukemia


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:4315

subject_name: Danazol

object_name: ovarian reserve


subject: CHEBI:71219

subject_name: Pazopanib

object_name: cervical cancer


subject: CHEBI:71219

object_name: cervical carcinoma


subject: UNII:OJE5810C4F

subject_name: Taxoprexin

object_name: prostate carcinoma


subject: UNII:OJE5810C4F

object_name: prostate cancer


subject: UMLS:C0218184

subject_name: Kogenate

object_name: hematologic disorder


subject: UMLS:C0961271


subject: PUBCHEM.COMPOUND:16158207

subject_name: LINACLOTIDE ACETATE

object_name: irritable bowel syndrome with constipation


subject: UNII:NSF067KU1M


subject: UMLS:C2000262

subject_name: MD-1100 acetate


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: esophageal squamous cell carcinoma


subject: CHEBI:76004

subject_name: Dimethyl fumarate

object_name: brain aneurysm


subject: CHEBI:76004

object_name: vascular inflammations


subject: UMLS:C1251704

subject_name: Lidocaine Patch

object_name: Effects of heat


subject: CHEBI:17650

object_name: cocaine use disorder


subject: CHEBI:15355

subject_name: Acetylcholine

object_name: type 2 diabetes mellitus


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate

object_name: osteoporosis


subject: UNII:9603LN7R2Q

object_name: Encounter due to family history of osteoporosis


subject: UNII:9603LN7R2Q

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:9603LN7R2Q

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:16919

subject_name: Creatine


subject: CHEBI:16919


subject: CHEBI:16919


subject: CHEBI:16919


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone

object_name: fetal growth restriction


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: CHEBI:135010

subject_name: Enoximone

object_name: COPD exacerbation


subject: CHEBI:2668

subject_name: Amlodipine

object_name: thalassemia


subject: CHEBI:43996

subject_name: Mitoguazone

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:43996

object_name: non-Hodgkin lymphoma


subject: CHEBI:43996

object_name: HIV infection


subject: UMLS:C2347423

subject_name: OncoGel

object_name: carcinoma of esophagus


subject: UMLS:C2347423

object_name: esophageal cancer


subject: UMLS:C2347423

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C2347423

object_name: neoplasm of esophagus


subject: UMLS:C2347423

object_name: esophageal adenocarcinoma


subject: UMLS:C2347423

object_name: squamous cell carcinoma


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: epilepsy


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:176724

subject_name: Etiracetam

object_name: post-traumatic stress disorder


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Delayed Emergence from Anesthesia


subject: UMLS:C4726559

subject_name: Anti-PRL-3 Monoclonal Antibody PRL3-zumab

object_name: liver carcinoma


subject: UMLS:C4726559

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4726559

object_name: Stomach cancer


subject: UMLS:C4726559

object_name: gastric cancer


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: primary peritoneal carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: papillary serous cystadenocarcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: peritoneal carcinoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:5134

subject_name: Fluticasone

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:5134

object_name: vitiligo


subject: UNII:0M78EU4V9H

subject_name: Lanthanum carbonate

object_name: smallpox


subject: CHEBI:3310

subject_name: Calcium acetate


subject: UNII:9YCX42I8IU

subject_name: sevelamer carbonate


subject: CHEBI:192761

subject_name: Iron sucrose


subject: CHEBI:83766

subject_name: Olaparib

object_name: HRD positive advanced ovarian cancer


subject: CHEBI:83766

object_name: BRCA Hereditary Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:165135384

object_name: BRCA1 gene mutation


subject: PUBCHEM.COMPOUND:165135384


subject: PUBCHEM.COMPOUND:165135384


subject: PUBCHEM.COMPOUND:165135384

object_name: BRCA Hereditary Breast Carcinoma


subject: PUBCHEM.COMPOUND:165135384

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:165135384

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:165135384

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:165135384

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:165135384

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:165135384

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:165135384

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:165135384

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:165135384

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:165135384

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:165135384

object_name: breast cancer


subject: UMLS:C5908005

subject_name: USP1 Inhibitor TNG348


subject: UMLS:C5908005


subject: UMLS:C5908005


subject: UMLS:C5908005


subject: UMLS:C5908005


subject: UMLS:C5908005


subject: UMLS:C5908005


subject: UMLS:C5908005


subject: UMLS:C5908005


subject: UMLS:C5908005


subject: UMLS:C5908005


subject: UMLS:C5908005


subject: UMLS:C5908005


subject: UMLS:C5908005


subject: UMLS:C5908005


subject: CHEBI:231679

subject_name: ipilimumab

object_name: rectal carcinoma


subject: CHEBI:231679

object_name: rectal cancer


subject: UMLS:C5787250

subject_name: Tramacet

object_name: Post-Operative Pain


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: glioma


subject: CHEBI:79699

object_name: malignant glioma


subject: CHEBI:79699

object_name: High grade glioma


subject: UMLS:C5884577

subject_name: ketoprofen topical 10% topical cream

object_name: Muscle strain


subject: UMLS:C5884577

object_name: strain symptom


subject: UMLS:C5884577

object_name: Sprain


subject: CHEBI:16118

subject_name: Berberine


subject: CHEBI:49603

subject_name: Lapatinib

object_name: lung adenocarcinoma


subject: CHEBI:49603

object_name: cervical adenocarcinoma


subject: CHEBI:49603

object_name: adenocarcinoma


subject: CHEBI:49603

object_name: bile duct adenocarcinoma


subject: CHEBI:49603

object_name: gastric adenocarcinoma


subject: UMLS:C1384663

object_name: esophageal adenocarcinoma


subject: UMLS:C1384663


subject: UMLS:C1384663


subject: UMLS:C1384663


subject: UMLS:C1384663


subject: UMLS:C1384663


subject: CHEBI:18248

subject_name: Iron

object_name: heart failure


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: osteoarthritis


subject: CHEBI:47097

subject_name: Lonafarnib

object_name: hepatobiliary disorder


subject: CHEBI:47097

object_name: liver disorder


subject: UMLS:C4043002

subject_name: peginterferon lambda-1a


subject: UMLS:C4043002


subject: UMLS:C4043002

object_name: hepatitis D


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:45409


subject: UNII:B5TAN0L720

subject_name: Picoplatin

object_name: castration-resistant prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3544907

subject_name: PICOPLATIN


subject: UMLS:C4329340

subject_name: Nisevokitug

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: CHEBI:3757

subject_name: Clonidine

object_name: endometriosis


subject: CHEBI:3757

object_name: Postoperative Pain, Acute


subject: CHEBI:3757

object_name: Acute Pain


subject: GTOPDB:8926

subject_name: glembatumumab vedotin

object_name: melanoma


subject: UNII:1568H6A58U


subject: UMLS:C2698156


subject: UNII:0125DUV5XC

subject_name: varlilumab


subject: CHEBI:8499

subject_name: Propranolol


subject: UNII:DF2O3JG5D2

object_name: Advanced cancer


subject: UMLS:C4085986


subject: UMLS:C4549686

object_name: Stage 3 chronic kidney disease


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: Unexplained infertility


subject: PUBCHEM.COMPOUND:134506

object_name: Turner syndrome


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:499361

subject_name: Aprepitant

object_name: Primary dysmenorrhea


subject: PUBCHEM.COMPOUND:5148108

subject_name: Resiniferatoxin

object_name: Knee pain


subject: CHEBI:50858

subject_name: corticosteroid

object_name: acute lymphoblastic leukemia


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UMLS:C1705207

subject_name: Endostar

object_name: mucosal melanoma


subject: CHEBI:16664

subject_name: Albendazole

object_name: tuberculosis


subject: CHEBI:195280

subject_name: Artemether

object_name: Instantaneous clearance


subject: CHEBI:156095

subject_name: Lumefantrine


subject: UNII:EGC16R10V0

subject_name: DALANTERCEPT

object_name: Advanced renal cell carcinoma


subject: UMLS:C2981815

subject_name: Dalantercept


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: carcinoma of esophagus


subject: UNII:8M7YSN2KII

object_name: esophageal cancer


subject: UNII:8M7YSN2KII

object_name: Childhood Esophageal Carcinoma


subject: UNII:8M7YSN2KII

object_name: neoplasm of esophagus


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: CHEBI:85083

subject_name: Sofosbuvir

object_name: HIV infection CDC category A1


subject: PUBCHEM.COMPOUND:66811198

subject_name: SIMEPREVIR


subject: CHEBI:93772

subject_name: Ispinesib

object_name: Recurrent Rectal Cancer


subject: CHEBI:93772

object_name: stage IVA rectal cancer


subject: CHEBI:93772

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:93772

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:93772

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:93772

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEBI:93772

object_name: stage IVB rectal cancer


subject: CHEBI:93772

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: CHEBI:93772

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: CHEBI:93772

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: CHEBI:93772

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: CHEBI:93772

object_name: stage IIIA rectal cancer


subject: CHEBI:93772

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: CHEBI:93772

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: CHEBI:93772

object_name: Stage IIIC Colon Cancer AJCC v8


subject: CHEBI:93772

object_name: Stage IIIC Colon Cancer AJCC v7


subject: CHEBI:93772

object_name: Colon cancer recurrent


subject: CHEBI:93772

object_name: Stage IIIA Colon Cancer AJCC v7


subject: CHEBI:93772

object_name: Stage IIIA Colon Cancer AJCC v8


subject: CHEBI:93772

object_name: malignant large intestine neoplasm stage IIIb


subject: CHEBI:93772

object_name: Stage IIIB Colon Cancer AJCC v8


subject: CHEBI:93772

object_name: Stage IIIB Colon Cancer AJCC v7


subject: CHEBI:93772

object_name: stage IVB colon cancer


subject: CHEBI:93772

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:93772

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:93772

object_name: stage IVA colon cancer


subject: CHEBI:93772

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:93772

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:33325

subject_name: radium atom

object_name: non-small cell lung carcinoma


subject: UMLS:C3827153


subject: CHEBI:145421

subject_name: rigosertib sodium

object_name: acute myeloid leukemia


subject: CHEBI:145421

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:145421

object_name: acute lymphoblastic leukemia


subject: CHEBI:145421

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C2347619


subject: UMLS:C2347619


subject: UMLS:C2347619


subject: UMLS:C2347619


subject: UNII:6PJC3KPK6S


subject: UNII:6PJC3KPK6S


subject: UNII:6PJC3KPK6S

object_name: acute myeloid leukemia by FAB classification


subject: UNII:6PJC3KPK6S


subject: UNII:6PJC3KPK6S

object_name: non-Hodgkin lymphoma


subject: UNII:6PJC3KPK6S

object_name: Hodgkin Disease


subject: UNII:6PJC3KPK6S

object_name: plasma cell myeloma


subject: UMLS:C1541384

subject_name: TLR7 Agonist 852A


subject: UMLS:C1541384


subject: UMLS:C1541384


subject: UMLS:C1541384


subject: UMLS:C1541384


subject: UMLS:C1541384


subject: UMLS:C1541384


subject: CHEBI:231679

subject_name: ipilimumab

object_name: digestive system cancer


subject: CHEBI:231679

object_name: female reproductive organ cancer


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: Carcinoma breast stage IV


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: UMLS:C5706401

subject_name: Anti-TROP2 Antibody-drug Conjugate BL-M02D1

object_name: Childhood Breast Carcinoma


subject: UMLS:C5706401

object_name: breast carcinoma


subject: UMLS:C5706401

object_name: breast cancer


subject: UMLS:C2346567

subject_name: Recentin

object_name: cancer


subject: UMLS:C2346567

object_name: neoplasm


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Postoperative delirium


subject: MESH:C575872

subject_name: Xeno V

object_name: dentin sensitivity


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Complication of ventilation therapy


subject: CHEBI:28177

subject_name: Theophylline

object_name: congenital heart disease


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: EXCESS LMW-DNA


subject: CHEBI:64073

object_name: cocaine use disorder


subject: CHEBI:3724

subject_name: citalopram hydrobromide

object_name: autism


subject: CHEBI:36791

subject_name: Escitalopram


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Syncope Related to COVID-19


subject: CHEBI:7773

object_name: Syncope, CTCAE 5.0


subject: CHEBI:7773

object_name: Syncope


subject: UMLS:C4039583

subject_name: Chimeric antigen receptor

object_name: Adult Solid Neoplasm


subject: UMLS:C4039583

object_name: HER2 positive breast carcinoma


subject: UMLS:C4039583

object_name: HER2-positive gastric cancer


subject: UMLS:C4039583

object_name: HER2 protein overexpression


subject: UMLS:C4039583

object_name: HER2 gene amplification


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Cardiovascular System Finding


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Respiratory System Finding


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Increased reactive oxygen species production


subject: UMLS:C5139951

object_name: chronic pancreatitis


subject: UMLS:C5139803


subject: PUBCHEM.COMPOUND:18759444

subject_name: Docusate sodium

object_name: Constipation


subject: PUBCHEM.COMPOUND:18759444

object_name: Constipation, CTCAE


subject: PUBCHEM.COMPOUND:18759444

object_name: Encounter due to palliative care


subject: CHEBI:534

subject_name: Docusate


subject: CHEBI:34974

subject_name: sennoside


subject: CHEBI:34974


subject: CHEBI:34974


subject: CHEBI:34975

subject_name: sennoside B


subject: CHEBI:34975


subject: CHEBI:34975


subject: CHEBI:9112

subject_name: sennoside A


subject: UNII:3FYP5M0IJX

subject_name: Sennosides


subject: CHEBI:197437

subject_name: Mocetinostat

object_name: endogenous depression


subject: CHEBI:197437

object_name: major depressive disorder


subject: UMLS:C1831851


subject: UMLS:C1831851


subject: CHEBI:41060

subject_name: IBANDRONATE

object_name: plasma cell myeloma


subject: UNII:UMD7G2653W

subject_name: Ibandronate


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Post-Traumatic Headache


subject: UMLS:C0935965

object_name: glioblastoma


subject: UMLS:C0935965

object_name: Brain Stem Glioblastoma


subject: UMLS:C0935965

object_name: glioma susceptibility 1


subject: UMLS:C5238976

subject_name: Negalstobart

object_name: diffuse large B-cell lymphoma


subject: UMLS:C0037668

subject_name: Somatotropin-Releasing Hormone

object_name: heart failure


subject: UMLS:C0037668

object_name: congestive heart failure


subject: UNII:38RL9AE51Q

subject_name: Anifrolumab

object_name: lupus nephritis


subject: PUBCHEM.COMPOUND:25110515

subject_name: Ozanimod

object_name: Multiple sclerosis relapse


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: Pediatric Obesity


subject: UMLS:C0499161

subject_name: Not otherwise classified, antineoplastic drugs

object_name: ependymoblastoma


subject: UMLS:C0499161

object_name: embryonal tumor with multilayered rosettes


subject: PUBCHEM.COMPOUND:16681698

subject_name: Obatoclax mesylate

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:94522


subject: UNII:39200FJ43J

subject_name: [OBSOLETE] obatoclax mesylate


subject: UMLS:C1831948

subject_name: obatoclax mesylate


subject: UMLS:C1831949


subject: UMLS:C5447282

subject_name: CDK4/6 Inhibitor GLR2007


subject: UMLS:C5447282


subject: UMLS:C5447282


subject: UMLS:C5447282

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:6917983

subject_name: Foradil Aerolizer

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0939339


subject: GTOPDB:7970

subject_name: depatuxizumab mafodotin


subject: GTOPDB:7970


subject: UNII:F3R7A4P04N


subject: UNII:F3R7A4P04N


subject: UMLS:C4477221


subject: UMLS:C4477221


subject: CHEBI:2704

subject_name: Anastrozole

object_name: Depressed mood


subject: CHEBI:2704

object_name: Cancer patients and suicide and depression


subject: CHEBI:2704

object_name: Depressed - symptom


subject: CHEBI:2704

object_name: Depression, CTCAE


subject: CHEBI:2704

object_name: osteoporosis


subject: CHEBI:2704

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:2704

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:2704

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:2704

object_name: sarcopenia


subject: CHEBI:2704

object_name: Diabetes


subject: CHEBI:2704

object_name: diabetes mellitus


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor


subject: CHEBI:50790


subject: CHEBI:50790


subject: CHEBI:50790


subject: CHEBI:50790


subject: CHEBI:50790


subject: CHEBI:50790


subject: CHEBI:50790


subject: CHEBI:50790

object_name: hypogonadism


subject: CHEBI:50790


subject: CHEBI:50790

object_name: type 2 diabetes mellitus


subject: CHEBI:50790


subject: CHEBI:50790


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C3536820

subject_name: Aromatase Inhibitor [EPC]


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: CHEBI:84094

subject_name: testosterone sulfate


subject: CHEBI:84094


subject: CHEBI:84094


subject: CHEBI:84094


subject: CHEBI:84094


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: UMLS:C2348756

subject_name: Testosterone Gel


subject: UMLS:C2348756


subject: UMLS:C2348756


subject: UMLS:C2348756


subject: UMLS:C2348756


subject: UMLS:C2348756


subject: UMLS:C2348756


subject: UMLS:C2348756


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Complex regional pain syndrome I, unspecified


subject: CHEBI:33380

subject_name: thulium atom


subject: CHEBI:33380

object_name: Coronavinae infectious disease


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:74861


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:55460


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:30703


subject: UMLS:C3166394

subject_name: Tm antigen


subject: UMLS:C3166394


subject: PR:000002105

subject_name: thrombomodulin


subject: PR:000002105


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: respiratory distress syndrome in premature infants


subject: CHEBI:41879

object_name: lung disorder


subject: CHEBI:92994

subject_name: ambroxol

object_name: Lewy Bodies


subject: GTOPDB:13796

subject_name: serplulimab

object_name: Safety Issues


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: UMLS:C4745029

subject_name: HLX 10


subject: HMDB:HMDB0256702

subject_name: Porfimer Sodium

object_name: Locally Advanced Lung Carcinoma


subject: HMDB:HMDB0256702

object_name: Stage III Lung Cancer AJCC v8


subject: HMDB:HMDB0256702

object_name: Stage IIIC Lung Cancer AJCC v8


subject: HMDB:HMDB0256702

object_name: Stage IIIA Lung Cancer AJCC v8


subject: HMDB:HMDB0256702

object_name: Stage IIIB Lung Cancer AJCC v8


subject: HMDB:HMDB0256702

object_name: Childhood Solid Neoplasm


subject: HMDB:HMDB0256702

object_name: Adult Solid Neoplasm


subject: HMDB:HMDB0256702

object_name: Solid Neoplasm


subject: HMDB:HMDB0256702

object_name: small cell lung carcinoma


subject: UNII:Y3834SIK5F

subject_name: PORFIMER SODIUM


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:59CF90960T

object_name: ulcerative colitis


subject: CHEBI:35469

subject_name: antidepressant

object_name: Childhood Breast Carcinoma


subject: CHEBI:35469

object_name: breast carcinoma


subject: CHEBI:35469

object_name: breast cancer


subject: CHEBI:35469

object_name: Hot Flashes, CTCAE


subject: CHEBI:35469

object_name: Hot flashes


subject: UMLS:C0003289

subject_name: Antidepressive Agents


subject: UMLS:C0003289


subject: UMLS:C0003289


subject: UMLS:C0003289


subject: UMLS:C0003289


subject: UMLS:C0770259

subject_name: Dextrose 5% and Water

object_name: Insulin Sensitivity


subject: UMLS:C4508451

subject_name: Xanamem

object_name: Moderate dementia


subject: UMLS:C4508451

object_name: Mild dementia


subject: UMLS:C4508451

object_name: Alzheimer disease type 1


subject: UMLS:C4508451

object_name: Alzheimer disease


subject: CHEBI:94789

subject_name: Trimetazidine

object_name: cardiotoxicity


subject: CHEBI:465284

subject_name: Ganciclovir

object_name: Keratoconjunctivitis caused by adenovirus


subject: CHEBI:465284

object_name: Viral Shedding


subject: CHEBI:17394

subject_name: Theanine

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:17394

object_name: Malignant Solid Neoplasm


subject: UMLS:C0076380

subject_name: theanine


subject: UMLS:C0076380


subject: CHEBI:31596

subject_name: Febuxostat

object_name: Left Ventricular Diastolic Dysfunction, CTCAE


subject: CHEBI:31596

object_name: Left ventricular diastolic dysfunction


subject: CHEBI:31596

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:31596

object_name: metabolic syndrome X


subject: UMLS:C0304547

subject_name: Lactobacillus acidophilus preparation

object_name: diabetes mellitus


subject: UMLS:C0304547

object_name: cognitive disorder


subject: CHEMBL.COMPOUND:CHEMBL2109070

subject_name: LACTOBACILLUS ACIDOPHILUS


subject: CHEMBL.COMPOUND:CHEMBL2109070


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone

object_name: Disorder of transplanted kidney


subject: CHEBI:32090

subject_name: Rebamipide

object_name: Xerostomia


subject: UMLS:C5885900

subject_name: Ural

object_name: type 1 diabetes mellitus 1


subject: UMLS:C5885900

object_name: type 1 diabetes mellitus


subject: CHEBI:2955

subject_name: Azithromycin

object_name: mixed anxiety and depressive disorder


subject: UMLS:C5702862

subject_name: Via (brand name)

object_name: primary central nervous system lymphoma


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: Childhood Breast Carcinoma


subject: CHEBI:49900

object_name: breast carcinoma


subject: CHEBI:49900

object_name: breast cancer


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: CHEBI:8863

subject_name: Riluzole

object_name: spinal cord injury


subject: UMLS:C0700599

subject_name: pyrimethamine / sulfadoxine

object_name: Neonatal death


subject: UMLS:C0700599

object_name: Premature infant


subject: UMLS:C0700599

object_name: Premature birth


subject: UMLS:C0700599

object_name: abortion


subject: UMLS:C0700599

object_name: Fetal Death


subject: UMLS:C0060061

subject_name: Fansidar

object_name: HIV infection


subject: UMLS:C0060061


subject: UMLS:C0060061


subject: UMLS:C0060061


subject: UMLS:C0060061


subject: UMLS:C0060061


subject: UNII:90ZX3Q3FR7

subject_name: Risankizumab


subject: UMLS:C4078397


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: EXCESS LMW-DNA


subject: PUBCHEM.COMPOUND:11394238

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:11394238

object_name: major depressive disorder


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: primary biliary cholangitis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C5417944

subject_name: Anti-PD-1 Monoclonal Antibody 609A

object_name: sarcoma


subject: UMLS:C5417944

object_name: soft tissue sarcoma


subject: CHEBI:7563

subject_name: N-nicotinoylglycine

object_name: Prediabetes


subject: CHEBI:7563

object_name: glucose intolerance


subject: CHEBI:7563

object_name: Impaired glucose tolerance


subject: MESH:D009539

subject_name: Nicotinic Acids


subject: MESH:D009539


subject: MESH:D009539


subject: UMLS:C3714626

subject_name: Nicotinic Acid Drug Class


subject: UMLS:C3714626


subject: UMLS:C3714626


subject: CHEBI:15940

subject_name: Niacin


subject: CHEBI:15940


subject: CHEBI:15940


subject: UMLS:C3536880

subject_name: Nicotinic Acid [EPC]


subject: UMLS:C3536880


subject: UMLS:C3536880


subject: CHEBI:233331

subject_name: Elamipretide

object_name: inborn mitochondrial metabolism disorder


subject: CHEBI:233331

object_name: mitochondrial disease


subject: CHEBI:233331

object_name: Mitochondrial pathology


subject: CHEBI:233331

object_name: Mitochondrial DNA deletion


subject: CHEBI:233331

object_name: mitochondrial DNA depletion syndrome


subject: CHEBI:233331

object_name: Mitochondrial metabolism defect


subject: CHEBI:233331

object_name: mitochondrial complex I deficiency, nuclear type 1


subject: CHEBI:233331

object_name: mitochondrial complex I deficiency


subject: UMLS:C4279623


subject: UMLS:C4279623


subject: UMLS:C4279623


subject: UMLS:C4279623


subject: UMLS:C4279623


subject: UMLS:C4279623


subject: UMLS:C4279623


subject: UMLS:C4279623


subject: UMLS:C5856324

subject_name: HPV16 RG1 VLP Vaccine

object_name: HPV-related carcinoma


subject: UMLS:C3864947

subject_name: Gardasil 9


subject: CHEBI:5931

subject_name: insulin human

object_name: peripheral vascular disease


subject: UMLS:C0876064

subject_name: Lantus


subject: UMLS:C5447489

object_name: Colorectal cancer recurrent


subject: UMLS:C5447489

object_name: metastatic colorectal cancer


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:135423438

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:135423438

object_name: breast cancer


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: UNII:E3B2GI648A

subject_name: Belatacept

object_name: proteinuria


subject: UNII:E3B2GI648A

object_name: Proteinuria of undiagnosed cause


subject: UNII:E3B2GI648A

object_name: Proteinuria, CTCAE 3.0


subject: UNII:E3B2GI648A

object_name: Proteinuria, CTCAE 5.0


subject: UMLS:C0020554

subject_name: Hypertonic Solutions

object_name: coronary artery disorder


subject: UMLS:C0020554

object_name: coronary atherosclerosis


subject: UNII:YSL2GUT2Q8

subject_name: RILVEGOSTOMIG

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:YSL2GUT2Q8

object_name: skin squamous cell carcinoma


subject: UNII:YSL2GUT2Q8

object_name: trabecular adenocarcinoma


subject: UNII:YSL2GUT2Q8

object_name: cutaneous neuroendocrine carcinoma


subject: UNII:YSL2GUT2Q8

object_name: nonpapillary renal cell carcinoma


subject: UNII:YSL2GUT2Q8

object_name: clear cell renal carcinoma


subject: UNII:YSL2GUT2Q8

object_name: renal cell adenocarcinoma


subject: UNII:YSL2GUT2Q8

object_name: renal cell carcinoma


subject: UNII:YSL2GUT2Q8

object_name: melanoma


subject: UMLS:C5706461

subject_name: Rilvegostomig


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UNII:MJ95C3OH47

subject_name: olive leaf extract

object_name: Prehypertension


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: Advanced Soft Tissue Sarcoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Esophageal gastric cardia type metaplasia


subject: UNII:5S371K6132

object_name: Stage III Esophageal Cancer


subject: UMLS:C0392939

subject_name: recombinant human thrombopoietin

object_name: carcinoma of esophagus


subject: UMLS:C0392939

object_name: esophageal cancer


subject: UMLS:C0392939

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C0392939

object_name: neoplasm of esophagus


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:834YJF89WO

subject_name: Belumosudil

object_name: Plasma cell myeloma refractory


subject: GTOPDB:11592

subject_name: evorpacept


subject: CHEMBL.COMPOUND:CHEMBL4297880

subject_name: EVORPACEPT


subject: UMLS:C4329513


subject: UNII:10WR240QN7

subject_name: PEGENZILEUKIN


subject: UMLS:C5206716


subject: UMLS:C4687517


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: myocardial ischemia


subject: UNII:M89N0Q7EQR

object_name: Family history of ischemic heart disease


subject: UMLS:C4687480

subject_name: Nanoparticle Paclitaxel Ointment SOR007

object_name: Secondary malignant neoplasm of skin


subject: UNII:75G4TW236W

subject_name: Meglumine antimoniate

object_name: Localized cutaneous leishmaniasis


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: type C thymoma


subject: GTOPDB:9592

object_name: thymoma


subject: GTOPDB:9592

object_name: thymus neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UNII:GKF8S4C432

subject_name: Anlotinib


subject: UNII:GKF8S4C432


subject: UNII:GKF8S4C432


subject: UMLS:C0243071

subject_name: Analog


subject: CHEBI:57397

subject_name: prostaglandin E1(1-)


subject: CHEBI:15544

subject_name: Alprostadil


subject: CHEBI:2663

subject_name: Amiodarone

object_name: Other intraoperative cardiac functional disturbances during cardiac surgery


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:51817

subject_name: Temocillin

object_name: bacteriemia


subject: CHEBI:51817

object_name: Bacteremia, CTCAE


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Takayasu arteritis


subject: CHEBI:91400

subject_name: Afatinib

object_name: gastric neoplasm


subject: UMLS:C4287766


subject: UMLS:C4289943

subject_name: Bacillus calmette-guerin substrain tokyo 172-1 live antigen

object_name: bladder carcinoma in situ


subject: UMLS:C4289943

object_name: non-invasive bladder urothelial carcinoma


subject: UMLS:C4289943

object_name: Bladder transitional cell carcinoma stage I


subject: CHEBI:31705

subject_name: Iodixanol

object_name: diabetes mellitus


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Advanced Gastrointestinal Stromal Tumor


subject: CHEBI:68647

subject_name: Regorafenib


subject: UMLS:C2703114


subject: UNII:19J3781LPM

subject_name: Itacitinib

object_name: bronchiolitis obliterans syndrome


subject: UNII:XZG407XE0Y

subject_name: ITACITINIB ADIPATE


subject: UMLS:C5204064

subject_name: Itacitinib Adipate


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: aneurysm


subject: GTOPDB:4985

object_name: EXCESS LMW-DNA


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UNII:21P2M98388

subject_name: Henagliflozin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:21P2M98388

object_name: obesity


subject: UNII:21P2M98388

object_name: Obesity, CTCAE


subject: UNII:21P2M98388

object_name: Myocardial fibrosis


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: articular cartilage; degeneration


subject: CHEBI:150712

object_name: Articular cartilage disorder of knee


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Alzheimer disease type 1


subject: CHEBI:41423

object_name: Alzheimer disease


subject: CHEBI:41423

object_name: Presenile dementia


subject: CHEBI:41423

object_name: dementia


subject: UMLS:C0042395

subject_name: vasoactive intestinal peptide

object_name: migraine


subject: UMLS:C0042395

object_name: migraine with or without aura, susceptibility to, 1


subject: UMLS:C0042395

object_name: sign or symptom


subject: UMLS:C0042395

object_name: Neurologic Manifestations


subject: UMLS:C0042395

object_name: CNS disorder


subject: UMLS:C0042395

object_name: brain disorder


subject: PUBCHEM.COMPOUND:16129679

subject_name: VIP


subject: PUBCHEM.COMPOUND:16129679


subject: PUBCHEM.COMPOUND:16129679


subject: PUBCHEM.COMPOUND:16129679


subject: PUBCHEM.COMPOUND:16129679


subject: PUBCHEM.COMPOUND:16129679


subject: CHEBI:80331

subject_name: Vasoactive intestinal peptide


subject: CHEBI:80331


subject: CHEBI:80331


subject: CHEBI:80331


subject: CHEBI:80331


subject: CHEBI:80331


subject: PUBCHEM.COMPOUND:70691420

subject_name: Aviptadil


subject: PUBCHEM.COMPOUND:70691420


subject: PUBCHEM.COMPOUND:70691420


subject: PUBCHEM.COMPOUND:70691420


subject: PUBCHEM.COMPOUND:70691420


subject: PUBCHEM.COMPOUND:70691420


subject: CHEBI:27732

subject_name: Caffeine

object_name: Second Stage of Labor


subject: UNII:8HV55C85DW

object_name: schizophrenia


subject: UMLS:C3272772

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C3272772

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C3272772

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:45783

subject_name: Imatinib


subject: CHEBI:45783


subject: CHEBI:3392

subject_name: Carbendazim

object_name: Acute migraine


subject: CHEBI:3392


subject: CHEBI:168480

subject_name: Desoxylimonin


subject: CHEBI:168480


subject: PR:000001406

subject_name: tumor necrosis factor receptor superfamily member 17


subject: PR:000001406


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Refractory Pancreatic Neuroendocrine Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Locally Advanced Pancreatic Neuroendocrine Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic Pancreatic Neuroendocrine Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Unresectable Pancreatic Neuroendocrine Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Refractory Digestive System Neuroendocrine Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Locally Advanced Digestive System Neuroendocrine Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic Digestive System Neuroendocrine Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Unresectable Digestive System Neuroendocrine Carcinoma


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: PUBCHEM.COMPOUND:6012

subject_name: Durandro

object_name: hypogonadism, male


subject: MESH:C000627770

subject_name: folfirinox

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Brain Stem Glioblastoma


subject: CHEBI:45716

subject_name: Vorinostat

object_name: glioblastoma


subject: CHEBI:45716


subject: CHEBI:45716

object_name: glioma susceptibility 1


subject: CHEBI:90217

subject_name: Quizartinib

object_name: myeloproliferative neoplasm


subject: CHEBI:90217

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:90217

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:90217

object_name: Recurrent Chronic Myelomonocytic Leukemia


subject: CHEBI:90217

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:90217

object_name: chronic myelomonocytic leukemia


subject: DRUGBANK:DB11357

subject_name: Linseed oil

object_name: type 2 diabetes mellitus


subject: DRUGBANK:DB11357

object_name: Insulin resistance


subject: DRUGBANK:DB11357

object_name: hypertriglyceridemia


subject: DRUGBANK:DB11357

object_name: Hypertriglyceridemia, CTCAE


subject: DRUGBANK:DB11357

object_name: obesity due to melanocortin 4 receptor deficiency


subject: DRUGBANK:DB11357

object_name: obesity


subject: DRUGBANK:DB11357

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion

object_name: Dyspnea


subject: PUBCHEM.COMPOUND:2307

object_name: Dyspnea, CTCAE


subject: PUBCHEM.COMPOUND:2307

object_name: cardiovascular surgery result: dyspnea


subject: PUBCHEM.COMPOUND:2307

object_name: Wheezing, CTCAE


subject: CHEBI:3001

subject_name: beclomethasone


subject: CHEBI:3001


subject: CHEBI:3001


subject: CHEBI:3001


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Netherton syndrome


subject: CHEBI:37845

subject_name: growth hormone

object_name: Burn injury


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: UMLS:C0021665

subject_name: Insulin-Like Growth Factor I


subject: PR:000009182

subject_name: insulin-like growth factor 1


subject: UMLS:C0123707

subject_name: Insulin-Like Growth Factor Binding Protein 3


subject: PR:000008949

subject_name: insulin-like growth factor-binding protein 3


subject: CHEBI:94366

subject_name: itraconazole


subject: CHEBI:231679

subject_name: ipilimumab

object_name: anal margin carcinoma


subject: CHEBI:231679

object_name: anal carcinoma


subject: CHEBI:231679

object_name: Kaposi Sarcoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C5392742

object_name: endometriosis


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: glucose metabolism disease


subject: UNII:420K487FSG

object_name: eosinophilic gastritis


subject: UMLS:C3658854


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: esophageal adenocarcinoma


subject: CHEBI:49900

object_name: Stage IV Esophageal Cancer AJCC v6


subject: CHEBI:49900

object_name: Stage IV Esophageal Cancer AJCC v7


subject: CHEBI:49900

object_name: stage IV esophageal cancer


subject: CHEBI:49900

object_name: Stage III Esophageal Cancer AJCC v7


subject: CHEBI:49900

object_name: Stage III Esophageal Cancer


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UMLS:C3152525

subject_name: Buffered Lidocaine

object_name: prostate carcinoma


subject: UMLS:C3152525

object_name: prostate cancer


subject: UMLS:C1581084

subject_name: sodium bicarbonate 8.4 %


subject: UMLS:C1581084


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: stiff-person syndrome


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: premature ejaculation


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: UMLS:C1548480

subject_name: hepatitis E vaccine

object_name: hepatitis E


subject: UMLS:C5238973

subject_name: Anti-PD-1/CD47 Fusion Protein HX009

object_name: melanoma


subject: UMLS:C5238973

object_name: biliary tract cancer


subject: UMLS:C5238973

object_name: liver carcinoma


subject: UMLS:C5237721

subject_name: FAK1 Inhibitor IN10018


subject: UMLS:C5237721


subject: UMLS:C5237721


subject: CHEBI:9150

subject_name: Simvastatin

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C1328169

object_name: Myelodysplasia


subject: UMLS:C1328169

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C1328169

object_name: childhood myelodysplastic syndrome


subject: UMLS:C1328169

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:125427


subject: CHEBI:125427


subject: CHEBI:125427


subject: CHEBI:125427


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Congenital heart disease in children


subject: CHEBI:74705

object_name: Child Malnutrition


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: psoriasis 14, pustular


subject: UNII:FU77B4U5Z0

object_name: pustulosis palmaris et plantaris


subject: UMLS:C1174389

object_name: non-small cell lung carcinoma


subject: CHEBI:135697

subject_name: Sarpogrelate

object_name: diabetic kidney disease


subject: UNII:5ZHA5P4PFX

subject_name: Dalpiciclib

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:23279496

subject_name: uridine triacetate

object_name: opiate dependence


subject: PUBCHEM.COMPOUND:23279496

object_name: Withdrawal Symptoms


subject: PUBCHEM.COMPOUND:23279496

object_name: Craving


subject: UMLS:C5854647

subject_name: FLT3 Inhibitor BMF-500

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5854647

object_name: acute myeloid leukemia


subject: HMDB:HMDB0033369

subject_name: Hydroxypropyl methylcellulose

object_name: Disorder of intraocular pressure


subject: HMDB:HMDB0033369

object_name: Intraocular Pressure


subject: HMDB:HMDB0033369

object_name: glaucoma


subject: HMDB:HMDB0033369

object_name: Glaucoma, CTCAE


subject: CHEBI:30618

subject_name: hydroxypropyl methylcellulose


subject: CHEBI:30618


subject: CHEBI:30618


subject: CHEBI:30618


subject: CHEMBL.COMPOUND:CHEMBL2108956

subject_name: HYPROMELLOSE


subject: CHEMBL.COMPOUND:CHEMBL2108956


subject: CHEMBL.COMPOUND:CHEMBL2108956


subject: CHEMBL.COMPOUND:CHEMBL2108956


subject: UNII:B1QE5P712K

subject_name: hypromellose 2208 (100 MPA.S)


subject: UNII:B1QE5P712K


subject: CHEBI:60787

subject_name: TIMOLOL


subject: CHEBI:60787


subject: CHEBI:39465

subject_name: timolol


subject: CHEBI:39465


subject: CHEBI:50217

subject_name: selegiline

object_name: impotence


subject: CHEBI:50217

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:50217

object_name: Erectile dysfunction


subject: CHEBI:71940

subject_name: Tadalafil

object_name: Parkinson disease


subject: CHEBI:184662

object_name: Primary Graft Dysfunction


subject: CHEBI:184662

object_name: natural killer cell mediated immunity


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEMBL.COMPOUND:CHEMBL256907


subject: CHEBI:63608

subject_name: Maraviroc


subject: CHEBI:63608


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: severe combined immunodeficiency


subject: CHEBI:72296

subject_name: Apixaban

object_name: blood coagulation disease


subject: MESH:C478756

subject_name: sini tang

object_name: Severe Sepsis


subject: UMLS:C0879578

object_name: lung cancer


subject: UMLS:C0879578

object_name: lung neoplasm


subject: UMLS:C0879578

object_name: lung carcinoma


subject: UMLS:C5706445

subject_name: RAS Inhibitor RMC-6236


subject: UMLS:C5706445


subject: UMLS:C5706445


subject: UMLS:C5706445

object_name: RAS Family Gene Mutation


subject: UMLS:C5706445

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C5706445

object_name: thoracic cancer


subject: UMLS:C5706445

object_name: MTAP Gene Deletion


subject: PUBCHEM.COMPOUND:168201327


subject: PUBCHEM.COMPOUND:168201327


subject: PUBCHEM.COMPOUND:168201327


subject: PUBCHEM.COMPOUND:168201327


subject: PUBCHEM.COMPOUND:168201327


subject: PUBCHEM.COMPOUND:168201327


subject: PUBCHEM.COMPOUND:168201327


subject: UMLS:C5907933

subject_name: KRAS G12D Inhibitor RMC-9805


subject: UMLS:C5907933


subject: UMLS:C5907933


subject: UMLS:C5907933


subject: UMLS:C5907933


subject: UMLS:C5907933


subject: UMLS:C5907933


subject: UMLS:C5854475

subject_name: PRMT5 Inhibitor TNG462


subject: UMLS:C5854475


subject: UMLS:C5854475


subject: UMLS:C5854475

object_name: Matthew-Wood syndrome


subject: UMLS:C5854475

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5854475


subject: UMLS:C5854475

object_name: non-small cell lung carcinoma


subject: UMLS:C5854475


subject: UMLS:C5854475


subject: UMLS:C5854475


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: DRUGBANK:DB17583

object_name: melanoma


subject: DRUGBANK:DB17583


subject: DRUGBANK:DB17583

object_name: N-ras gene mutation


subject: CHEBI:145371

subject_name: Binimetinib


subject: CHEBI:145371


subject: UMLS:C1512511

subject_name: Human Papilloma Virus Vaccine

object_name: Infection


subject: UMLS:C1512511

object_name: infectious disease


subject: UMLS:C1512511

object_name: Adverse Event Associated with Infection


subject: PUBCHEM.COMPOUND:6450346

subject_name: Ganglioside GD2

object_name: Childhood Neuroblastoma


subject: PUBCHEM.COMPOUND:6450346

object_name: neuroblastoma


subject: CHEBI:28648


subject: CHEBI:28648


subject: CHEBI:53287


subject: CHEBI:53287


subject: CHEBI:61370

subject_name: poly(stearyl methacrylate) polymer


subject: CHEBI:61370


subject: UMLS:C1120338

subject_name: casein phosphopeptide-amorphous calcium phosphate nanocomplex


subject: UMLS:C1120338


subject: UMLS:C1120338


subject: UMLS:C1120338

object_name: Xerostomia


subject: UMLS:C1120338

object_name: Dry Mouth, CTCAE


subject: UMLS:C1120338

object_name: mucositis


subject: UMLS:C3642376

object_name: adult lymphoma


subject: UMLS:C3642376

object_name: lymphoma


subject: UMLS:C3642376

object_name: pediatric lymphoma


subject: UNII:KM31LBX59H

subject_name: Florbenazine F-18

object_name: Parkinson disease


subject: UMLS:C2934037


subject: CHEBI:29708

subject_name: Zinc gluconate

object_name: noise induced hearing loss


subject: CHEBI:29708

object_name: Tinnitus, Noise Induced


subject: CHEBI:29708

object_name: Zinc deficiency


subject: CHEBI:33198

subject_name: Gluconic Acid


subject: CHEBI:33198


subject: CHEBI:33198


subject: PUBCHEM.COMPOUND:23664049

subject_name: SODIUM GLUCONATE


subject: PUBCHEM.COMPOUND:23664049


subject: PUBCHEM.COMPOUND:23664049


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: Unresectable Urothelial Carcinoma


subject: UNII:Y6BX7BL23K

object_name: Metastatic urothelial carcinoma


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: cystoid macular edema


subject: CHEBI:6931

subject_name: Midazolam

object_name: Extrusive luxation of tooth


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:64198

subject_name: Dimercaprol


subject: PR:000015049

subject_name: long-chain fatty acid transport protein 5


subject: PR:000012301


subject: PR:000005317

subject_name: bile salt-activated lipase


subject: CHEBI:24433

subject_name: group


subject: UNII:0T0250N43U

subject_name: peginterferon lambda-1a

object_name: Hepatitis D, Chronic


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Diabetes


subject: PUBCHEM.COMPOUND:156963194

subject_name: 17-hydroxyprogesterone caproate

object_name: preterm premature rupture of the membranes


subject: UMLS:C2365254

subject_name: Granisetron Transdermal Patch

object_name: Chemotherapy-induced nausea and vomiting


subject: UMLS:C5779650

object_name: primary biliary cholangitis 1


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:30314

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:30314

object_name: neurotoxicity


subject: CHEBI:17460

subject_name: Thioctamide


subject: CHEBI:17460


subject: CHEBI:17460


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: CHEBI:16494


subject: MESH:C000720496

subject_name: ABNCoV2 vaccine


subject: MESH:C000720496

object_name: severe acute respiratory syndrome


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab


subject: PUBCHEM.COMPOUND:3417

object_name: neonatal sepsis


subject: PUBCHEM.COMPOUND:3417

object_name: Bacterial sepsis of newborn


subject: CHEBI:62247


subject: CHEBI:62247


subject: CHEBI:62419


subject: CHEBI:62419


subject: CHEBI:28915

subject_name: Fosfomycin


subject: CHEBI:28915


subject: UMLS:C0951745

subject_name: alpha-glucoheptonic acid, magnesium salt (2:1)

object_name: Critical Illness


subject: UNII:3A3U0GI71G

subject_name: Magnesium oxide


subject: CHEBI:31794

subject_name: magnesium oxide


subject: CHEBI:8884

subject_name: Rocuronium

object_name: anesthesia; functional


subject: UNII:X8JR0I7JE1

subject_name: TALACOTUZUMAB

object_name: Myelodysplasia


subject: PR:000007691

subject_name: ferritin heavy polypeptide-like 17

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: UMLS:C2718754

subject_name: Ilaris

object_name: Wet age-related macular degeneration


subject: CHEBI:64356

subject_name: Pregabalin

object_name: Shivering


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: Maternity blues


subject: CHEBI:6715

object_name: Finding of lactation


subject: CHEBI:16919

subject_name: Creatine

object_name: Frail elderly syndrome


subject: UMLS:C0074926

subject_name: Soy Proteins


subject: CHEBI:6520

subject_name: Lomustine

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:6520

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:4715169

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:4715169

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:4715169

object_name: Visceral Pain


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:64356


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Recurrent Malignant Head and Neck Neoplasm


subject: CHEBI:46058

subject_name: TAXOTERE


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: morbid obesity


subject: CHEBI:77260

subject_name: Omeprazole


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: diffuse large B-cell lymphoma


subject: UNII:52CMI0WC3Y

object_name: Lymphoma, Large-Cell, Follicular


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3892863

subject_name: filgrastim-sndz

object_name: plasma cell myeloma


subject: MESH:C094948

object_name: obesity due to melanocortin 4 receptor deficiency


subject: MESH:C094948

object_name: obesity


subject: MESH:C094948

object_name: Obesity, CTCAE


subject: MESH:C094948

object_name: Overweight


subject: UNII:GE077RPG04

subject_name: RACLOPRIDE C 11


subject: UNII:GE077RPG04


subject: UNII:GE077RPG04


subject: UNII:GE077RPG04


subject: UMLS:C0752264

subject_name: Raclopride C11


subject: UMLS:C0752264


subject: UMLS:C0752264


subject: UMLS:C0752264


subject: UNII:9UMA2EEO9Q

object_name: cancer


subject: UNII:9UMA2EEO9Q

object_name: neoplasm


subject: UMLS:C2830123


subject: UMLS:C2830123


subject: CHEBI:63610

subject_name: Misoprostol

object_name: cervical incompetence


subject: UMLS:C3641122

object_name: hereditary papillary renal cell carcinoma


subject: CHEBI:231369

subject_name: Savolitinib

object_name: clear cell renal carcinoma


subject: CHEBI:231369


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX

object_name: papillary renal cell carcinoma


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Impacted tooth


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Acute Heart Failure Related to COVID-19


subject: CHEBI:9241

object_name: Acute heart failure


subject: CHEBI:17313

subject_name: Daphnetin

object_name: Lymphedema of lower extremity


subject: PUBCHEM.COMPOUND:9852982

subject_name: Ceftaroline

object_name: bacterial pneumonia


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN


subject: CHEBI:63598

subject_name: Levofloxacin


subject: PUBCHEM.COMPOUND:72562361

subject_name: Ceftaroline fosamil


subject: UMLS:C5707295

subject_name: Fluorine F 18 Para-chloro-2-fluoroethyl-etomidate

object_name: Non-secretory adrenocortical adenoma


subject: UMLS:C5707295

object_name: adrenal gland hyperfunction


subject: UMLS:C5707295

object_name: ACTH-independent Cushing syndrome


subject: UMLS:C5707295

object_name: primary aldosteronism due to aldosterone producing adenoma


subject: UMLS:C5707295

object_name: primary aldosteronism due to nodular hyperplasia


subject: UMLS:C5707295

object_name: adrenal carcinoma


subject: UMLS:C5707295

object_name: adrenal cortex carcinoma


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: cystic, mucinous, and serous neoplasm


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6801

subject_name: Metformin

object_name: Liver Fibrosis


subject: CHEBI:6801

object_name: Injury of liver


subject: CHEBI:73611

subject_name: Met-Gly

object_name: Alzheimer disease


subject: CHEBI:25107

subject_name: magnesium atom


subject: PR:000004501

subject_name: attractin


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0700004

subject_name: Megace

object_name: Hyperplasia of the endometrium


subject: UMLS:C0700004

object_name: Adverse effects


subject: UMLS:C0700004

object_name: Regression


subject: UMLS:C0700004

object_name: infertility


subject: CHEBI:231594

subject_name: Norgestrel


subject: CHEBI:231594


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol


subject: PUBCHEM.COMPOUND:3080587


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: Harmful pattern of substance use


subject: CHEBI:127342

object_name: substance abuse


subject: UMLS:C5203471

subject_name: Dexmedetomidine Liquid Injection

object_name: Insufficient Anesthesia


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:DLG4EML025

subject_name: Secukinumab


subject: CHEBI:84040

object_name: COPD, severe early onset


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: hypertension


subject: CHEBI:15927

object_name: Hypertension, CTCAE


subject: CHEBI:4653

subject_name: Dipyridamole

object_name: type 2 diabetes mellitus


subject: CHEBI:4653

object_name: Diabetes


subject: CHEBI:4653

object_name: diabetes mellitus


subject: CHEBI:36704

subject_name: Imiquimod

object_name: Bowen's Disease


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Recurrent Brain Neoplasm


subject: CHEBI:5118

object_name: primary brain neoplasm


subject: CHEBI:5118

object_name: brain cancer


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Chronic liver disease


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C4079949

object_name: kidney failure


subject: UMLS:C2827706

subject_name: Buprenorphine Transdermal Matrix Patch

object_name: opiate dependence


subject: UMLS:C2827706

object_name: Buprenorphine withdrawal


subject: UMLS:C2827706

object_name: pregnancy disorder


subject: UMLS:C2827706

object_name: high-risk pregnancy


subject: UMLS:C2827706

object_name: pregnancy related


subject: UNII:4B3SC438HI

subject_name: METHYLPHENIDATE HYDROCHLORIDE

object_name: conduct disorder


subject: CHEBI:6887

subject_name: Methylphenidate


subject: CHEBI:51041

subject_name: Acamprosate

object_name: anxiety


subject: CHEBI:51041

object_name: Anxiety symptoms


subject: CHEBI:51041

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:51041

object_name: Anxiety, CTCAE 5.0


subject: MESH:D008081

subject_name: Liposomes

object_name: Kaposi Sarcoma


subject: MESH:D008081

object_name: HIV infection


subject: UMLS:C0260264

subject_name: steroid drugs

object_name: myasthenia gravis


subject: UMLS:C0260264

object_name: Myasthenia Gravis, CTCAE


subject: CHEBI:136053

subject_name: Nemonoxacin

object_name: bacterial pneumonia


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Bacterial Colonization


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: acute leukemia


subject: UNII:581F7DFA9B

subject_name: Olorinab

object_name: irritable bowel syndrome


subject: CHEBI:26536

subject_name: retinoic acid

object_name: Her2-receptor negative breast cancer


subject: CHEBI:28870


subject: CHEBI:15367

subject_name: Tretinoin


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:6067

subject_name: Isotretinoin


subject: CHEBI:17688

subject_name: Nicotine

object_name: post-traumatic stress disorder


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Caesarean section


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:49575

subject_name: Diazepam

object_name: Seizure Related to COVID-19


subject: CHEBI:49575

object_name: visual epilepsy


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: UMLS:C5908001

subject_name: CDC7 Inhibitor SGR-2921

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5908001

object_name: acute myeloid leukemia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Genital warts


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3086655

subject_name: Tiotropium

object_name: chronic bronchitis


subject: PUBCHEM.COMPOUND:11431811

subject_name: Tiotropium Bromide Monohydrate


subject: UMLS:C5666962

subject_name: Anti-LAG-3 Monoclonal Antibody HLX26

object_name: adult lymphoma


subject: UMLS:C5666962

object_name: lymphoma


subject: UMLS:C5666962

object_name: pediatric lymphoma


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Critical Illness


subject: CHEBI:17650

object_name: Fluid Overload


subject: CHEBI:17650

object_name: Hypervolemia


subject: CHEBI:33283

subject_name: THIAMINE


subject: CHEBI:33283


subject: UMLS:C3714802

subject_name: Thiamine Drug Class


subject: UMLS:C3714802


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:18385


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: CHEBI:63453

object_name: urothelial carcinoma


subject: CHEBI:63453

object_name: transitional cell carcinoma


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Borrelia infectious disease


subject: CHEBI:51254

object_name: fissured tongue


subject: CHEBI:51254

object_name: geographic tongue


subject: CHEBI:51254

object_name: Lyme disease


subject: CHEBI:51254

object_name: early lyme disease


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: CHEBI:60648


subject: CHEBI:60648

object_name: Erythema migrans


subject: CHEBI:60648


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:27446

subject_name: Penicillin V


subject: CHEBI:27446


subject: CHEBI:27446


subject: CHEBI:27446


subject: CHEBI:27446


subject: CHEBI:27446


subject: UMLS:C1831904

subject_name: ThermoDox

object_name: Pancreatic cancer non-resectable


subject: UMLS:C1831904

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1831904

object_name: stage IV pancreatic cancer


subject: UMLS:C1831904

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C1831904

object_name: pancreatic ductal adenocarcinoma


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: Hospital acquired pneumonia


subject: UNII:6GNT3Y5LMF

object_name: Healthcare associated pneumonia


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: CHEBI:51799

subject_name: Imipenem


subject: CHEBI:51799


subject: CHEBI:190509


subject: CHEBI:190509


subject: UMLS:C4051515

subject_name: PCSK9 Inhibitor [EPC]

object_name: Hemodialysis access failure


subject: UMLS:C4521460

subject_name: Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action


subject: GTOPDB:13769

subject_name: retatrutide

object_name: cardiovascular disorder


subject: CHEMBL.COMPOUND:CHEMBL5095485

subject_name: RETATRUTIDE


subject: UMLS:C2000262

subject_name: MD-1100 acetate

object_name: Constipation


subject: UMLS:C2000262

object_name: Constipation, CTCAE


subject: CHEBI:134344

subject_name: Thioredoxins

object_name: influenza


subject: CHEBI:134344

object_name: Antioxidative Stress


subject: CHEBI:134344

object_name: Inflammation


subject: CHEBI:134344

object_name: common cold


subject: CHEBI:134344

object_name: Upper Respiratory Infections


subject: CHEBI:134344

object_name: chronic obstructive pulmonary disease


subject: CHEBI:4828

subject_name: Ergothioneine


subject: CHEBI:4828


subject: CHEBI:4828


subject: CHEBI:4828


subject: CHEBI:4828


subject: CHEBI:4828


subject: CHEBI:38747

subject_name: taxifolin


subject: CHEBI:38747


subject: CHEBI:38747


subject: CHEBI:38747


subject: CHEBI:38747


subject: CHEBI:38747


subject: PUBCHEM.COMPOUND:44567960

subject_name: VASOACTIVE INTESTINAL PEPTIDE

object_name: Common Migraine


subject: CHEBI:80331

subject_name: Vasoactive intestinal peptide


subject: UMLS:C0042395

subject_name: vasoactive intestinal peptide


subject: PUBCHEM.COMPOUND:70691420

subject_name: Aviptadil


subject: UNII:HTV56CD308

subject_name: baminercept

object_name: Primary Sjögren's syndrome


subject: UMLS:C3273012


subject: UMLS:C0392939

subject_name: recombinant human thrombopoietin

object_name: aplastic anemia


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Mycoses


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:145994

subject_name: Remdesivir

object_name: End stage renal failure on dialysis


subject: UNII:1Y3JD5PEMS

object_name: venous thromboembolism


subject: UNII:1Y3JD5PEMS

object_name: thrombophilia due to thrombin defect


subject: UMLS:C2607112


subject: UMLS:C2607112


subject: CHEBI:15765

subject_name: Levodopa

object_name: Cardiovascular event


subject: CHEBI:47426

subject_name: Furosemide

object_name: Cutaneous warts


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: Fasting


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C5203931

subject_name: TLR Agonist BSG-001

object_name: Malignant ascites


subject: UMLS:C5203931

object_name: Malignant pleural effusion


subject: UMLS:C0360032

subject_name: EMLA Cream

object_name: Extrusive luxation of tooth


subject: CHEBI:10033

subject_name: Warfarin

object_name: advanced heart failure


subject: CHEBI:42944

subject_name: Galantamine

object_name: Post-Traumatic Headache


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: metastatic colorectal cancer


subject: CHEBI:6413

subject_name: Letrozole

object_name: oligospermia


subject: CHEBI:6413

object_name: spermatogenic failure 3


subject: UMLS:C2697652

subject_name: IMT-1012 Immunotherapeutic Vaccine

object_name: Childhood Breast Carcinoma


subject: UMLS:C2697652

object_name: breast carcinoma


subject: UMLS:C2697652

object_name: breast cancer


subject: PUBCHEM.COMPOUND:89455219

subject_name: tirabrutinib

object_name: primary central nervous system lymphoma


subject: UMLS:C0722196

subject_name: Nutropin AQ

object_name: cystic fibrosis


subject: UNII:LX5H9JA46G

subject_name: BONE MORPHOGENETIC PROTEIN 2

object_name: BONE DEGENERATIVE CHANGES


subject: UNII:LX5H9JA46G

object_name: Degenerative disorder of bone


subject: UNII:LX5H9JA46G

object_name: osteoarthritis


subject: UNII:T472P45MG6

subject_name: Dibotermin alfa


subject: UNII:T472P45MG6


subject: UNII:T472P45MG6


subject: MESH:C551013

subject_name: Grazax

object_name: Atopic rhinitis


subject: MESH:C551013

object_name: Allergic Rhinitis, CTCAE


subject: PUBCHEM.COMPOUND:4689

subject_name: Paromomycin I

object_name: Chiclero ulcer


subject: CHEBI:233202


subject: CHEBI:7934

subject_name: Paromomycin


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:QQA9MLH692

subject_name: Tafasitamab

object_name: Polymorphic lymphoproliferative disorder following transplant


subject: UNII:QQA9MLH692


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: urticaria


subject: UNII:2P471X1Z11

object_name: reported urticaria (physical finding)


subject: UNII:2P471X1Z11

object_name: Urticaria, CTCAE


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UNII:R30772KCU0

subject_name: Isatuximab

object_name: cancer


subject: UNII:R30772KCU0

object_name: neoplasm


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: UNII:ZG6U44T8SG

subject_name: INTISMERAN AUTOGENE

object_name: in situ carcinoma


subject: UNII:ZG6U44T8SG

object_name: superficial urinary bladder carcinoma


subject: UNII:ZG6U44T8SG

object_name: bladder tumor


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: heart failure


subject: UMLS:C1145201

object_name: Heart Failure, CTCAE


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:7931


subject: CHEBI:48560

subject_name: Dopamine Agents

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: pain measurement


subject: UMLS:C0169964

subject_name: somatropin

object_name: hormone deficiency


subject: PUBCHEM.COMPOUND:168429557

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:168429557

object_name: obesity


subject: PUBCHEM.COMPOUND:168429557

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:168429557

object_name: type 2 diabetes mellitus


subject: UNII:DM3EKX84Y7


subject: UNII:DM3EKX84Y7


subject: UNII:DM3EKX84Y7


subject: UNII:DM3EKX84Y7


subject: CHEBI:36791

subject_name: Escitalopram

object_name: heart disorder


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:6456

subject_name: Lidocaine

object_name: morbid obesity


subject: CHEBI:231614

subject_name: Nivolumab

object_name: bladder disease


subject: CHEBI:231614

object_name: Female Urogenital Diseases and Pregnancy Complications


subject: CHEBI:231614

object_name: Female Urogenital Diseases


subject: CHEBI:231614

object_name: Male Urogenital Diseases


subject: CHEBI:231614

object_name: urinary system disorder


subject: CHEBI:231614

object_name: benign urinary system neoplasm


subject: CHEBI:231614

object_name: urinary system neoplasm


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:AF75XOF6W3

subject_name: Relatlimab


subject: UNII:AF75XOF6W3

object_name: bladder tumor


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3

object_name: Neoplasm of the genitourinary tract


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: CHEBI:33569

subject_name: noradrenaline

object_name: traumatic encephalopathy


subject: CHEBI:33569

object_name: acquired; coagulation defect


subject: CHEBI:33569

object_name: coagulation defect; bleeding


subject: CHEBI:33569

object_name: Fibrinolytic hemorrhage, acquired


subject: CHEBI:33569

object_name: blood coagulation disease


subject: CHEBI:166902


subject: CHEBI:166902


subject: CHEBI:166902


subject: CHEBI:166902


subject: CHEBI:166902


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: maturity-onset diabetes of the young type 1


subject: CHEBI:17347

subject_name: Testosterone


subject: UMLS:C0059079

subject_name: EMLA

object_name: Post-Operative Pain


subject: UNII:950O97NUPO

subject_name: Preladenant

object_name: childhood neoplasm


subject: UNII:950O97NUPO

object_name: neoplastic syndrome


subject: UNII:950O97NUPO

object_name: cancer or benign tumor


subject: UNII:950O97NUPO

object_name: neoplasm


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Epstein-Barr Virus Positive


subject: UNII:28X28X9OKV

object_name: Stage IV Nasopharyngeal Carcinoma


subject: UNII:28X28X9OKV

object_name: Nasopharyngeal cancer recurrent


subject: UNII:28X28X9OKV

object_name: Stage IV Nasopharyngeal Carcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage III Nasopharyngeal Carcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage III Nasopharyngeal Carcinoma


subject: UNII:28X28X9OKV

object_name: Stage IVB Nasopharyngeal Carcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IVA Nasopharyngeal Carcinoma AJCC v7


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: GTOPDB:8221

subject_name: epacadostat


subject: GTOPDB:8221


subject: GTOPDB:8221


subject: GTOPDB:8221


subject: GTOPDB:8221


subject: GTOPDB:8221


subject: GTOPDB:8221


subject: GTOPDB:8221


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UMLS:C3896947

subject_name: Fluorine F 18 Ara-G


subject: UMLS:C3896947

object_name: severe acute respiratory syndrome


subject: GTOPDB:12969

subject_name: tarlatamab

object_name: oligodendroglial tumor


subject: GTOPDB:12969

object_name: Adult Oligodendroglial Tumor


subject: GTOPDB:12969

object_name: oligodendroglioma


subject: GTOPDB:12969

object_name: childhood astrocytic tumor


subject: GTOPDB:12969

object_name: astrocytic tumor


subject: GTOPDB:12969

object_name: astrocytoma


subject: GTOPDB:12969

object_name: adult astrocytic tumor


subject: UNII:74X82ST8Q1

subject_name: TARLATAMAB


subject: UNII:74X82ST8Q1


subject: UNII:74X82ST8Q1


subject: UNII:74X82ST8Q1


subject: UNII:74X82ST8Q1


subject: UNII:74X82ST8Q1


subject: UNII:74X82ST8Q1


subject: UMLS:C4687660

subject_name: AMG 757


subject: UMLS:C4687660


subject: UMLS:C4687660


subject: UMLS:C4687660


subject: UMLS:C4687660


subject: UMLS:C4687660


subject: UMLS:C4687660


subject: UNII:5IB2J79MCX

subject_name: Spesolimab

object_name: psoriasis


subject: CHEBI:149509

object_name: Inflammation


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:8774

subject_name: Ramipril


subject: UMLS:C4726567

subject_name: Acyclic Nucleoside Phosphonate Prodrug ABI-1968

object_name: High Grade Squamous Intraepithelial Neoplasia


subject: UMLS:C4726567

object_name: Human Papilloma Virus, Female


subject: UMLS:C4726567

object_name: Human Papilloma Virus, Male


subject: UMLS:C4726567

object_name: cervical cancer


subject: UMLS:C4726567

object_name: cervical carcinoma


subject: UMLS:C4726567

object_name: Cervical high grade squamous intraepithelial lesion


subject: UMLS:C4726567

object_name: cervical intraepithelial neoplasia


subject: UMLS:C4726567

object_name: dysplasia of cervix


subject: UMLS:C4726567

object_name: uterine cervix neoplasm


subject: UMLS:C4726567

object_name: cervical polyp


subject: UMLS:C4726567

object_name: Cervical neoplasm


subject: UMLS:C4726567

object_name: Chronic idiopathic neutropenia


subject: UMLS:C4726567

object_name: cervical squamous intraepithelial neoplasia


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Intertrochanteric Fractures


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: ESR1 Gene Mutation


subject: CHEBI:35111

subject_name: calcium monohydroxide

object_name: Post-Operative Pain


subject: CHEBI:35150

subject_name: calcium hydroxide


subject: CHEBI:31341

subject_name: calcium dihydroxide


subject: UMLS:C0885450

subject_name: Iodoformum, iodoform, Homeopathic preparation


subject: UMLS:C0885450

object_name: dental pulp necrosis


subject: CHEBI:37758

subject_name: Iodoform


subject: CHEBI:37758


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Diabetes, Autoimmune


subject: UMLS:C1099192


subject: DRUGBANK:DB18525

object_name: amyloidosis


subject: DRUGBANK:DB18525

object_name: hereditary amyloidosis


subject: DRUGBANK:DB18525

object_name: polyneuropathy


subject: DRUGBANK:DB18525

object_name: Amyloid Neuropathies


subject: DRUGBANK:DB18525

object_name: familial amyloid neuropathy


subject: DRUGBANK:DB18525

object_name: inherited neurodegenerative disorder


subject: DRUGBANK:DB18525

object_name: peripheral nervous system disorder


subject: DRUGBANK:DB18525

object_name: neurodegenerative disease


subject: DRUGBANK:DB18525

object_name: neuromuscular disease


subject: DRUGBANK:DB18525

object_name: genetic disease


subject: DRUGBANK:DB18525

object_name: inborn errors of metabolism


subject: DRUGBANK:DB18525

object_name: nervous system disorder


subject: DRUGBANK:DB18525

object_name: metabolic disease


subject: DRUGBANK:DB18525

object_name: neuropathy


subject: UMLS:C5565871

subject_name: Paxlovid

object_name: uremia


subject: UMLS:C5565871

object_name: Increased NPN


subject: CHEBI:192712


subject: CHEBI:192712


subject: UNII:69VKY8P7EA

object_name: melanoma


subject: UMLS:C2004126

subject_name: TKI 258


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: Pregnant


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: CHEBI:30314

subject_name: Lipoic acid


subject: CHEBI:17460

subject_name: Thioctamide


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: nicotine dependence


subject: PUBCHEM.COMPOUND:11957447

subject_name: NOREPINEPHRINE BITARTRATE

object_name: biliary atresia


subject: PUBCHEM.COMPOUND:11957447

object_name: no feeling or sensation of skin


subject: PUBCHEM.COMPOUND:11957447

object_name: Sensory Loss


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: Scorpion sting


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: Malignant neoplasm of stomach stage III


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: GTOPDB:13796

subject_name: serplulimab


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: UMLS:C4745029

subject_name: HLX 10


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: Obstetric Labor Complications


subject: CHEBI:3311

object_name: Birthing Labor


subject: CHEBI:3311

object_name: LABOR ACTIVE DILATED CM


subject: CHEBI:4708

subject_name: Doxazosin

object_name: amphetamine abuse


subject: CHEBI:4708

object_name: mood disorder


subject: UNII:H5212R2DPM

object_name: Metastatic castration-resistant prostate cancer


subject: DRUGBANK:DB19210


subject: UMLS:C4078032

subject_name: AMG 811

object_name: EXCESS LMW-DNA


subject: UMLS:C4287712

subject_name: Anti-LAMP1 Antibody-drug Conjugate SAR428926

object_name: cancer


subject: CHEBI:8871

subject_name: Risperidone

object_name: Manic Episode


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Chemotherapy induced neutropenia


subject: CHEBI:3757

subject_name: Clonidine

object_name: hyperemesis gravidarum


subject: UMLS:C4053656

subject_name: pan-RAF Kinase Inhibitor CCT3833

object_name: melanoma


subject: UMLS:C4053656


subject: UMLS:C4053656

object_name: neoplasm


subject: CHEBI:93953

subject_name: Pyroxamide

object_name: small intestine cancer


subject: CHEBI:93953

object_name: small intestine carcinoma


subject: CHEBI:93953

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:93953

object_name: precancerous condition


subject: CHEBI:93953

object_name: myeloproliferative neoplasm


subject: CHEBI:93953

object_name: Myelodysplasia


subject: CHEBI:93953

object_name: adult lymphoma


subject: CHEBI:93953

object_name: lymphoma


subject: CHEBI:93953

object_name: pediatric lymphoma


subject: CHEBI:93953

object_name: leukemia


subject: CHEBI:93953

object_name: childhood leukemia


subject: CHEBI:94265

subject_name: Cerubidin

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:231350

subject_name: Pacritinib

object_name: Treatment related acute myeloid leukaemia


subject: CHEBI:231350

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:231350

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:231350


subject: UMLS:C5785368

subject_name: KRAS G12D Inhibitor HRS-4642

object_name: stage IV pancreatic cancer


subject: GTOPDB:7988

subject_name: nimotuzumab


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: CHEBI:32066

subject_name: Protionamide

object_name: multidrug-resistant tuberculosis


subject: PUBCHEM.COMPOUND:137628665

subject_name: S-Gboxin

object_name: brain stem glioma


subject: PUBCHEM.COMPOUND:137628665

object_name: diffuse intrinsic pontine glioma


subject: PUBCHEM.COMPOUND:137628665

object_name: H3 K27M Variant


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UMLS:C3827032

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:37845

subject_name: growth hormone

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: spinal cord injury


subject: CHEBI:38545

object_name: osteoporosis


subject: CHEBI:38545

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:38545

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:38545

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:167574

subject_name: Semaglutide

object_name: systemic sclerosis


subject: CHEBI:167574

object_name: fibrosis


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: Unresectable Colorectal Carcinoma


subject: UNII:6A901E312A

object_name: Metastatic Colorectal Carcinoma


subject: UNII:6A901E312A

object_name: Unresectable Rectal Adenocarcinoma


subject: UNII:6A901E312A

object_name: Stage IVB Rectal Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Unresectable Colon Adenocarcinoma


subject: UNII:6A901E312A

object_name: Stage III Rectal Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage IVA Rectal Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage IVC Rectal Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Metastatic rectal adenocarcinoma


subject: UNII:6A901E312A

object_name: Adenocarcinoma of colon metastatic


subject: UNII:6A901E312A

object_name: Stage III Colon Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage IIIB Colon Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage IIIA Colon Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage IIIC Colon Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage IVA Colon Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage IVB Colon Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage IVC Colon Cancer AJCC v8


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: carotid stenosis


subject: CHEBI:6775

subject_name: Mesalazine

object_name: HIV infection


subject: CHEBI:18248

subject_name: Iron

object_name: diarrhea


subject: CHEBI:18248

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:18248

object_name: Diarrhea, CTCAE


subject: CHEBI:29034

subject_name: Ferric cation


subject: CHEBI:29034


subject: CHEBI:29034


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C1166521


subject: UMLS:C1166521


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: UMLS:C3714701


subject: UMLS:C3714701


subject: GTOPDB:12962

subject_name: sotatercept

object_name: Solid Neoplasm